NEOGENOMICS INC Insider Trading for November 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEOGENOMICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEOGENOMICS INC for November 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 7.52 | 77,074 | 579,596 | 50,000 | |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Option Exercise | M | 7.52 | 72,926 | 548,404 | 127,074 | |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 45.48 | 77,074 | 3,505,326 | 370,902 | 448 K to 370.9 K (-17.20 %) |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 7.52 | 77,074 | 579,596 | 447,976 | 370.9 K to 448 K (+20.78 %) |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Sell | S | 45.19 | 52,926 | 2,391,726 | 370,902 | 423.8 K to 370.9 K (-12.49 %) |
Nov 25 2020 | NEO | NEOGENOMICS INC | CARDOZA GEORGE | President, Pharma S ... | Buy | M | 7.52 | 72,926 | 548,404 | 423,828 | 350.9 K to 423.8 K (+20.78 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 20,000 | 150,400 | 0 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 20,000 | 150,400 | 0 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 358,752 | 2,697,815 | 20,000 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 358,752 | 2,697,815 | 20,000 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 121,248 | 911,785 | 378,752 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Option Exercise | M | 7.52 | 121,248 | 911,785 | 378,752 | |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.34 | 100,000 | 4,234,000 | 2,422,790 | 2.5 M to 2.4 M (-3.96 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.34 | 100,000 | 4,234,000 | 2,422,790 | 2.5 M to 2.4 M (-3.96 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 20,000 | 150,400 | 2,522,790 | 2.5 M to 2.5 M (+0.80 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 20,000 | 150,400 | 2,522,790 | 2.5 M to 2.5 M (+0.80 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 41.56 | 118,752 | 4,935,333 | 2,502,790 | 2.6 M to 2.5 M (-4.53 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 41.56 | 118,752 | 4,935,333 | 2,502,790 | 2.6 M to 2.5 M (-4.53 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 358,752 | 2,697,815 | 2,621,542 | 2.3 M to 2.6 M (+15.85 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 358,752 | 2,697,815 | 2,621,542 | 2.3 M to 2.6 M (+15.85 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.18 | 121,248 | 5,114,241 | 2,262,790 | 2.4 M to 2.3 M (-5.09 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Sell | S | 42.18 | 121,248 | 5,114,241 | 2,262,790 | 2.4 M to 2.3 M (-5.09 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 121,248 | 911,785 | 2,384,038 | 2.3 M to 2.4 M (+5.36 %) |
Nov 16 2020 | NEO | NEOGENOMICS INC | VAN OORT DOUGLAS M | Chairman and CEO | Buy | M | 7.52 | 121,248 | 911,785 | 2,384,038 | 2.3 M to 2.4 M (+5.36 %) |
Nov 12 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Option Exercise | M | 7.85 | 15,000 | 117,750 | 0 | |
Nov 12 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Sell | S | 42.00 | 2,262 | 95,004 | 56,726 | 59 K to 56.7 K (-3.83 %) |
Nov 12 2020 | NEO | NEOGENOMICS INC | Pedulla Denise E | General Counsel | Buy | M | 7.85 | 15,000 | 117,750 | 58,988 | 44 K to 59 K (+34.10 %) |